|Day Low/High||7.15 / 7.83|
|52 Wk Low/High||6.14 / 40.40|
On Thursday investors await the final estimate of third-quarter gross domestic product, along with quarterly results from Rite Aid.
Shares of Fred's were up big Tuesday after the company announced an agreement to purchase 865 Rite Aid stores.
Jim Cramer asks whether Fred's Pharmacy can succeed in buying hundreds of Rite Aid stores.
U.S. stocks inched higher Tuesday, with the Dow Jones Industrial Average closing in on 20,000, despite alleged terror attacks in Berlin, Zurich and Turkey on Monday
Every time the index nears that benchmark, the market's going to sell off.
Fred Pharmacy opted out of the Q&A session during its third quarter earnings call due to an undisclosed acquisition.
We have a host of positives that can and do seem to be playing out.
I'm talking about head-to-head comparisons of companies.
Prospective deals are hijacking an earnings-based focus on fundamentals.
British American Tobacco's $47 billion offer to purchase Reynolds American could face hurdles from shareholders as well as regulators.
U.S. stocks accelerate losses throughout the morning as crude oil retreats from its highest level of the year.
It would block the early November rally you'd expect when this big event is, at last, past us.
Walgreens extends merger deadline with Rite Aid, and Telsa unveils its new product.
For starters, trouble for banks, drugs, energy and M&A.
U.S. stocks edged higher on Wednesday after a stream of positive earnings trickled in.
Walgreens is set to report quarterly results on Thursday ahead of the opening bell and TheStreet's Jim Cramer believes the drugstore chain should walk away from Rite Aid.
Rite Aid shares are up Thursday after posting second quarter earnings of $0.03 a share, a penny ahead of forecasts.
U.S. stocks rose on Thursday, fueled by the Federal Reserve's decision Wednesday to keep interest rates lower for longer.
Earnings and economic data are in focus for Thursday, September 22.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer isn't fond of how Rite Aid is being managed.
The Federal Reserve takes center stage for the week of September 19.
McKesson is down 10 percent year-to-date due to the heated political debate over drug pricing but the stock is too cheap to ignore.
Disappointment over the ECB's inaction and uncertainty over the Fed's rate plans left markets rattled.
Oil stocks surge on EIA data, while Rite Aid and Walgreens continue to push their pending deal forward.
Shares of Kroger were lower Wednesday. The supermarket chain has emerged as a buyer for stores of Rite Aid.
Jim Cramer says it's too early to buy grocery store stocks like Sprouts and Kroger.
U.S. stock losses accelerated throughout the morning after a reading on manufacturing activity in the U.S. fell into contraction.